In this study, we have confirmed that CHRDL2 represses BMP signalling in CRC cells, leading to elevated WNT signalling, and causes changes in cell growth, response to chemotherapy and stem‐cell characteristics. Here, CHRDL2 is linked to colorectal carcinoma.